Praised for its ‘depth and experience’, Hogan Lovells is well-equipped to advise clients in the pharmaceutical, medical device and healthcare industries, with expertise across transactional, regulatory, patent litigation and product liability matters. The firm handles collaborations, M&A and licensing transactions, and is also well-placed to advise on regulatory frameworks, compliance and agency investigations, with a particular focus on emerging technologies. The practice is also experienced in multijurisdictional patent and product liability litigation and IP lifecycle management, supported by its in-house scientific unit. The team is co-chaired by ’highly regarded’ patent litigator Stephen Bennett and regulatory specialist Jane Summerfield, who brings ’eminent’ regulatory knowledge and a commercial approach to clinical trials, marketing authorisations, and manufacturing licenses. Praised for his ‘innovative litigation strategy’, fellow co-lead Matthew Felwick leverages his scientific background in product liability and commercial disputes. Penny Powell focuses on complex commercial transactions, while Daniel Brook and Stella Wong handle patent disputes across jurisdictions.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- ‘Stephen Bennett is very highly regarded by all his peers. Daniel Brook is very careful and competent. Katie McConnell is also excellent. Highly rated associates include Imogen Ireland, Ian Moss and Helen Poulson and Raina Hayles.’
- 'Elise Martin is a pleasure to work with. She is an excellent communicator and works collaboratively with counsel - a real team player. She and I worked together on a product liability case involving tight deadlines, and she was calm, professional, and upbeat throughout (including taking calls on a bank holiday weekend).'
- 'Jane Summerfield is eminently knowledgeable, highly responsive, and cares deeply about delivering the right commercial solution for her clients.'
- ‘The strongest all-round patent department in London. Ably assisted by the offices around Europe doing UPC work.’
- 'The Hogan Lovells life sciences team in London is the undoubted market leader. A global strength for the firm, the London office in particular stands out for its depth and experience in the field. From global regulatory advice on bringing new life science products to the market to dealing with any liabilities arising, the team is outstanding in all respects.'
- 'Absolutely excellent client care from an exceptionally personable and knowledgeable team. They know their clients' businesses inside out and understand their commercial objectives.'
Key clients
- Recordati Industria Chimica E Farmaceutica SPA Eli Lilly Merck Sharp and Dohme (MSD) Astellas Pharmaceuticals Novartis AG Aztiq Molecular Partners Zimmer Biomet Viatris Akebia Therapeutics
Work highlights
Advised Recordati on the acquisition of global rights to Enjaymo® (sutimlimab) from Sanofi, with a potential matter value of US$1.075 billion.
Representing Lilly in an ongoing multi-jurisdictional dispute concerning their cancer drug, pemetrexed.
Advising Zimmer Biomet and its European subsidiaries regarding a voluntary recall of their NexGen Stemmed Option Tibial prosthetic knee component and coordinating the defence of personal injury claims across European jurisdictions.
Lawyers
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Next Generation Partners
Junior partners with significant recognition from clients and peers in the market and key roles on multiple matters.
Leading associates
Leading associates with regular involvement in their team's key work, and recognition from peers or clients as being ones to watch.
Elise Martin
Practice head
Jane Summerfield; Stephen Bennett; Matthew Felwick
Other key lawyers
Penny Powell; Daniel Brook; Stella Wong; Elise Martin; Katie McConnell; Imogen Ireland; Ian Moss; Helen Poulson; Raina Hayles; Lara Knight; Lucy Ward